Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Planet Labs (PL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Planet Labs — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Planet Labs trades at $17.51 (market cap $6.46B). The key difference: Planet Labs is far larger — about 3.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Planet Labs is more actively traded (10,188,839 versus 5,448,712). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Planet Labs for 4 Days on average.
| NUVB | PL | |
|---|---|---|
Market Cap | $1.71B | $6.46B |
Volume | 5,448,712 | 10,188,839 |
Sector | Health | Industrials |
52-Week High | $9.54 | $51.40 |
52-Week Low | $3.41 | $11.16 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $1.30B | $6.09B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Planet Labs
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →
